CrossR. J., GlashanR. W., HumphreyC. S., RobinsonM. R. G., SmithP. H., WilliamsR. E.: Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil. Brit. J. Urol., 48; 609–615 (1976).
2.
European Organisation for Research on Treatment of Cancer: Urological Group B.: The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil. Eur. Urol., 3; 276–278 (1977).
3.
MartinoS., SamalB., SarrafM.: Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract. Cancer Treat. Rep., 64; 161–163 (1980).
4.
McGeorgeA., HartA. J. L., RundleJ. S., McVieJ. C., CaimanK. C.: The treatment of advanced carcinoma of the bladder with combination chemotherapy. Brit. J. Urol., 54; 366–368 (1982).
5.
OgawaO., MasudaF.: Therapeutic experience of cisplatin, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer. Hinyokika Kiyo, 32; 795–802 (1986).
6.
SamalB., BakerL., IzbickiR.: Phase I - II trial of adriamycin (AD) and 5-fluorouracil (FU). Proc. Amer. Assoc. Cancer. Res. & Asco, 18; 312 (1977).
7.
SternbergC. N., YagodaA., ScherH. I., WatsonR. C., AhmedT., WeiselbergL. R., GellerN., HollanderP. S., HerrH. W., SoganiP. C., MorseM. J., WhitmoreW. F.: Preliminary results of M-Vac (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol., 133; 403–407 (1985).
8.
StoterG., DenisL., SplinterT. A. W.: Chemotherapy for metastatic bladder carcinoma. J. Urol., 3; 110–112 (1985).
9.
StoterG., SplinterT. A. W., ChildJ. A., FossaS. D., DenisL., Van OosteromA. T., De PauwM., SilvesterR. (European Organization for Research on Treatment of Cancer Genito-Urinary Group): Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder. J. Urol., 137; 663–667 (1987).
10.
TashiroK., MachidaT., MasudaF., OihishiY.: Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide and 5-fluorouracil. Cancer Chem. Pharm., 11 (suppl.); 43–46 (1983).
11.
TronerM., BirchR., OmuraG. A., WilliamsJ. R.: Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer (Southeastern Cancer Study Group Trial). J. Urol., 137; 660–662 (1987).
12.
TurnerA. G., HendryW. F., WilliamsG. B., BloomH. J. G.: The treatment of advanced bladder cancer with methotrexate. Brit. J. Urol., 49; 673–678 (1978).
13.
VeronesiU., LagriM. D., FigoliF., TirelliU., GalligioniE., TrovoM., MerloA., Dal BoV., TumuloS., GrigolettoE.: Combination chemotherapy with adriamcyin and 5-fluorouracil in advanced carcinoma. Clin. Oncol., 8; 103–106 (1982).
WilliamsS. D., DonohueJ. P., EinhornL. H.: Advanced bladder cancer: Therapy with Cis-dichlorodiammineplatinum (II), adriamycin and 5-fluorouracil. Cancer Treat. Rep., 63; 1573–1576 (1979).
16.
YagodaA., WatsonR. C., WhitmoreW. F.: Adriamycin in advanced urinary tract cancer. Experience in 42 patients and review of the literature. Cancer, 39; 279–285 (1977).